We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
Price data last checked 12 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 79 days • 79 data points (No recent data available)
Price Distribution
Price distribution over 79 days • 1 price levels
Price Analysis
Most common price: £520 (79 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 79 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLQYMSTH
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in India
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in India
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments for US Zip Codes
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes
The 2023-2028 Outlook for Alpha-1 Antitrypsin Drugs for US Zip Codes
The 2023-2028 Outlook for Air Treatment Products in the United States
The 2023 Report on Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies: World Market Segmentation by City
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
The 2023-2028 Outlook for Animal Health Active Pharmaceutical Ingredients in the United States
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2023-2028 Outlook for Business-to-Business (B2B) Same-Day Deliveries in the United States
The 2023-2028 Outlook for Children's Cough, Cold, and Allergy Medicines in the United States
